Abiopharma

News list

Cheng Andrew 🟢 acquired 30.4K shares (1 derivative) of Damora Therapeutics, Inc. (DMRA) at $31.00 Transaction Date: Aug 12, 2026 | Filing ID: 349537

Full text

News bot Aug. 13, 2026, 9:22 p.m.
🔍 Cheng Andrew (Executive)

Company: Damora Therapeutics, Inc. (DMRA)

Report Date: 2026-08-12
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 30,350
Detailed Transactions and Holdings:
- Acquired 30,350 shares of Stock Option (right to buy) at $31.0 per share (Derivative)
  Date: 2026-08-12 | Code: A | Expires: 2036-08-12 | equity_swap_involved: false | shares_owned_after: 30,350.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: This option represents a right to purchase shares of common stock of the Issuer. This option will vest in equal monthly installments through August 12, 2029, subject to the Reporting Person's continued service to the Issuer on each such vesting date.